EASING ACCESS
TO THE NEXT-GENERATION
OF OSD DRUG PRODUCT CONTROL

Addressing today’s and tomorrow’s
quality control challenges

As the pharmaceutical industry shifts from batch to continuous manufacturing, conventional quality control methods are no longer sufficient to meet rising regulatory expectations for better control of OSD drug product quality.

Anticipating this evolution more than five years ago, Pharma Technology began developing versatile solutions that integrate advanced Process Analytical Technologies (PAT) to monitor and control Critical Quality Attributes (CQAs).

By combining multidisciplinary scientific expertise, our R&D team has designed equipment that makes advanced quality control more accessible, supporting the industry’s move towards Quality by Design and real-time process understanding.

Embedded technologies

We integrate the most advanced technologies into our quality control solutions and make them easy to use through carefully designed software interfaces.

Advanced analytical technologies used for pharmaceutical quality control are often perceived as complex and difficult to implement, which can discourage their adoption. Pharma Technology develops QC solutions designed to reshape how these technologies are used in oral solid dosage (OSD) product development and manufacturing by making them more accessible, practical, and reliable.

3D Laser

NIR-SRS

4P Tester

3D Microwave

CQA analysis

Depending on your specific application and quality control objectives, our solutions can monitor and control different sets of Critical Quality Attributes (CQAs), using either destructive or non-destructive analytical approaches. This flexibility allows pharmaceutical companies to select the most appropriate methodology according to their product characteristics, development stage, and manufacturing environment.

Our systems are designed with scalability and adaptability in mind. As regulatory expectations evolve and new CQAs need to be measured or predicted, the platform can be upgraded with additional analytical capabilities, software functionalities, or chemometric models. This ensures that our solutions not only address today’s quality control requirements but are also prepared to support the future needs of pharmaceutical development and manufacturing.

Expert support for tailored control solutions

Because every process involves unique parameters and each product comes with its own set of critical attributes to monitor, our scientific experts support you in building tailored chemometric models adapted to your specific application.

Quality control challenge understanding:

Pharma Technology begins every collaboration by gaining a clear understanding of the quality control challenges faced by the client. By analysing the product characteristics, the manufacturing process, and the Critical Quality Attributes (CQAs) that need to be monitored, our scientific team identifies the most relevant analytical approach. This initial assessment allows us to configure the CUB-X platform and develop the appropriate chemometric models to address the client’s specific application and ensure reliable, actionable quality control.